Acton, MA, United States of America

Insulet Corporation


USPTO Granted Patents = 242

% Expired Patents = 2.9



Trademarks = 19

Forward Citations = 15,594

Loading Chart...
Loading Chart...

172 inventors (with patents filed for the assignee):

goldMedal Joon Bok Lee (51 out of 51 patents)

silverMedal David I Nazzaro (51 out of 79 patents)

bronzeMedal Yibin Zheng (46 out of 54 patents)

4.  Ian T McLaughlin (44 out of 44 patents)

5.  Jason B O'Connor (40 out of 40 patents)

6.  Steven P Cardinali (31 out of 59 patents)

7.  Daniel Allis (28 out of 28 patents)

8.  Jason O'connor (27 out of 27 patents)

9.  Ashutosh Zade (22 out of 23 patents)

10.  Maureen McCaffrey (22 out of 22 patents)

11.  J Christopher Flaherty (17 out of 267 patents)

12.  Sandhya Pillalamarri (17 out of 17 patents)

13.  Jorge Borges (17 out of 17 patents)

14.  Bryan Mazlish (14 out of 79 patents)

15.  Kevin Guido Schmid (14 out of 14 patents)


Core Competencies:
Insulin Delivery
Drug Delivery Device
Glucose Monitoring
Wearable Device
Positive Displacement Pump
Medication Delivery
Automated Systems
Fluid Analysis
Closed Loop Control
Personalized Treatment
Safety Constraints
Infusion Pump

242 patents:

Insulet Corporation, headquartered in Acton, Massachusetts, specializes in innovative automated drug delivery systems, primarily focusing on insulin delivery for diabetes management. The company is renowned for its development of wearable devices that integrate advanced glucose monitoring and medication delivery technologies. Insulet's core expertise lies in positive displacement pumps and automated systems that enhance fluid analysis, aiming to improve patient outcomes through seamless and efficient drug delivery solutions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Insulet Corporation
242 Patents

#1 in Acton, MA

#105 in Massachusetts

#1,754 in US

#3,570 in the World

Acton, MA (US)
Acton, MA, United States of America
Forward Citations = 15,594

172 inventors:

Please report any incorrect information to [email protected]
Loading…